A Chemically Defined TLR3 Agonist with Anticancer Activity.
Le Naour J, Thierry S, Scuderi SA, Boucard-Jourdin M, Liu P, Bonnin M, Pan Y, Perret C, Zhao L, Mao M, Renoux C, Pérez-Lanzón M, Martin B, Kepp O, Kroemer G, Werlé B.
Le Naour J, et al. Among authors: boucard jourdin m.
Oncoimmunology. 2023 Jun 27;12(1):2227510. doi: 10.1080/2162402X.2023.2227510. eCollection 2023.
Oncoimmunology. 2023.
PMID: 37389102
Free PMC article.